Non classé
Immunotherapy drug nivolumab approved in Europe as adjuvant treatment for patients with oesophageal cancer
The European Commission (EC) recently approved nivolumab (Opdivo®) for the treatment of patients with oesophageal or gastro-oesophageal junction (...
DiCE Projects Ensure Patient Involvement in Basic and Clinical Research
Discover our projects bringing patient involvement into basic and clinical cancer research – overviews to be given in our Masterclass
...
All.Can – Cancer Care Efficiency Resources for DiCE Members
All.Can – Cancer Efficiency Resources for DiCE Members
...
Screening patients with colorectal cancer cost-effectively for Lynch syndrome
Lynch syndrome is a hereditary syndrome; it results from mutations (genetic changes) in inherited genes that are responsible for fixing errors in t...
French Cancer Patients Publically Raise Their Voice on Pandemic Treatment Effects
The effects of the pandemic on cancer patients and others with severe diseases is starting to show – French patient associations published th...
For all CRC Survivors! Please Take Part in Survey for Better Care
Are you a colon cancer survivor? Would you like to contribute to a collaborative research project that aims at improving cancer care for cancer sur...
